首页> 外文期刊>Molecular medicine reports >Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease
【24h】

Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease

机译:慢性阻塞性肺病急性加剧的内皮祖细胞功能障碍

获取原文
获取原文并翻译 | 示例
           

摘要

Endothelial progenitor cells (EPCs) are decreased in cardiac dysfunction morbidity associated with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Therefore, the present study aimed to assess the role of EPCs in AECOPD. Patients with AECOPD (n=27) or stable COPD (n=26) were enrolled. Systemic inflammatory markers (high-sensitivity C-reactive protein) were measured. In addition, EPCs were counted, isolated and cultured, and their proliferative, migratory, adhesive and tube-forming capabilities were determined, in cells from patients with AECOPD and stable COPD. EPC number was lower in patients with AECOPD (5.1 +/- 2.6x10(3)/ml) compared with patients with stable COPD (6.0 +/- 3.2x10(3)/ml). Migration assay indicated that the early-EPCs isolated from patients with AECOPD were significantly less mobile than EPCs derived from stable COPD subjects, at a stromal-cell derived factor-1 alpha concentration of 100 ng/ml (3,550/30,000 vs. 7,853/30,000, P<0.05). C-X-C chemokine receptor-4 positivity was significantly reduced in AECOPD patients (16.1 +/- 9.9 vs. 56.33 +/- 6.3%, P<0.05). Furthermore, fewer early-EPC clusters were formed by EPCs derived from AECOPD, compared with those derived from stable COPD (8.2 +/- 0.86 vs. 14.4 +/- 1.36, P=0.027). Stable COPD late-EPCs were markedly deficient in intact tubule formation, however AECOPD late-EPCs formed no tubules. The number of AECOPD-and stable COPD-derived late-EPCs adhering to Matrigel-induced tubules was 36.8 +/- 1.85 and 20.6 +/- 1.36 (P<0.05) respectively, and the cluster of differentiation 31 positivity in late-EPCs was 79.69 +/- 1.3 and 29.1 +/- 2.47%, in AECOPD and stable COPD patients, respectively (P<0.001). The findings demonstrated that early-EPCs are decreased and dysfunctional in AECOPD patients, which may contribute to the altered vascular endothelium in this patient population.
机译:内皮祖细胞(EPC)在慢性阻塞性肺病(AECOPD)的急性加剧相关的心脏功能障碍发病率下降。因此,本研究旨在评估EPCS在AECOPD中的作用。注册了患有AECOPD(n = 27)或稳定COPD(n = 26)的患者。测量全身炎症标志物(高敏感性C反应蛋白)。此外,对EACOPD患者和稳定COPD患者的细胞中测定了EPCS,分离和培养,并确定了它们的增殖性,迁移,粘合剂和管形成能力。与稳定COPD患者(6.0 +/- 3.2×10(3)/ mL)相比,EPC编号(5.1 +/- 2.6x10(3)/ mL)较低。迁移检测表明,从艾彼普德患者分离的早期EPCS比衍生自稳定COPD受试者的EPC患者,其基质 - 细胞衍生因子-1α浓度为100ng / ml(3,550 / 30,000与7,853 / 30,000 ,p <0.05)。 AECOPD患者的C-X-C趋化因子受体-4阳性显着降低(16.1 +/- 9.9与56.33 +/- 6.3%,P <0.05)。此外,与源自稳定COPD的那些(8.2 +/- 0.86,P = 0.027)相比,通过源自AECOPD的EPCS形成更少的早期EPC簇。稳定的COPD后期EPC在完整的小管形成中显着缺乏,但是EACOPD后期的EPC没有形成小管。粘附在Matrigel诱导的小管中的AECOPD和稳定COPD衍生的后期的数量分别为36.8 +/- 1.85和20.6 +/- 1.36(P <0.05),并且在后期EPCS中的分化31阳性79.69 +/- 1.3和29.1 +/- 2.47%,分别在AECOPD和稳定的COPD患者中(P <0.001)。研究结果表明,早期EPC在艾普普波德患者中减少和功能性功能不全,这可能导致该患者群体的改变的血管内皮。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号